Overview
- 45 inspections across 44 sites are on record.
- 50 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-19.
At a glance
Inspections
45
Sites
44
Observations
50
Career since
Jun 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Quagen Pharmaceuticals LLC | 19 May 2026 | Human Drugs | |
| Daiichi Sankyo, Inc. | 4 May 2026 | Human Drugs | |
| Eric B.J. Segal, M.D. | 2 Apr 2026 | Human Drugs | |
| Somerset Medical Center IRB | 11 Mar 2026 | Medical Devices & Rad Health | On file |
| BeOne Medicines USA, Inc. | 17 Feb 2026 | Human Drugs | On file |
Sites inspected
Quagen Pharmaceuticals LLCWest Caldwell, United States1 insp.
Daiichi Sankyo, Inc.Basking Ridge, United States1 insp.
Eric B.J. Segal, M.D.Hackensack, United States1 insp.
Somerset Medical Center IRBSomerville, United States1 insp.
BeOne Medicines USA, Inc.Pennington, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Michael Serrano8 shared
Tyanna N Hadley2 shared
Jonah S Ufferfilge2 shared
Jogy George2 shared
Jordan C Desilva1 shared
Mayar M Mussa1 shared
Ana C Lazo1 shared
Jessica S Estriplet1 shared
Charlotte P Chang1 shared
Samir C Gala1 shared
Full investigator report
Get the verbatim findings behind Jay B Shah's 50 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site